s6y Oncotelic Therapeutics, Inc. EFFECT

Oncotelic Therapeutics, Inc. EFFECT, filed Aug 25, 2009: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 25, 2009
Accession Number: 0000950123-09-035562
Submission Type: POS AM
CIK: 0000908259
Company Name: OXIGENE INC
File Number: 333-150595